Coloplast A/S

CPSE:COLO B Lagerbericht

Marktkapitalisierung: kr.191.5b

Coloplast Management

Management Kriterienprüfungen 4/4

Coloplast's CEO ist Kristian Villumsen, ernannt in Dec 2018, hat eine Amtszeit von 5.42 Jahren. Die jährliche Gesamtvergütung beträgt DKK23.30M, bestehend aus 51.5% Gehalt und 48.5% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.045% der Aktien des Unternehmens, im Wert von DKK85.51M. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 6.1 Jahre bzw. 6.3 Jahre.

Wichtige Informationen

Kristian Villumsen

Geschäftsführender

kr.23.3m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts51.5%
Amtszeit als Geschäftsführer5.5yrs
Eigentum des Geschäftsführers0.05%
Durchschnittliche Amtszeit des Managements6.2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder6.4yrs

Jüngste Management Updates

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Recent updates

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Apr 13
Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Mar 29
Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 12
Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Coloplast (CPH:COLO B) Could Easily Take On More Debt

Jan 12
Coloplast (CPH:COLO B) Could Easily Take On More Debt

Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Dec 28
Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

Nov 25
Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Oct 31
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Oct 02
Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Sep 16
Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Aug 02
Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Jul 01
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Jun 16
Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Kristian Villumsen im Vergleich zu den Einnahmen von Coloplast verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

kr.5b

Dec 31 2023n/an/a

kr.5b

Sep 30 2023kr.23mkr.12m

kr.5b

Jun 30 2023n/an/a

kr.5b

Mar 31 2023n/an/a

kr.5b

Dec 31 2022n/an/a

kr.5b

Sep 30 2022kr.21mkr.12m

kr.5b

Jun 30 2022n/an/a

kr.5b

Mar 31 2022n/an/a

kr.5b

Dec 31 2021n/an/a

kr.5b

Sep 30 2021kr.22mkr.11m

kr.5b

Jun 30 2021n/an/a

kr.5b

Mar 31 2021n/an/a

kr.4b

Dec 31 2020n/an/a

kr.4b

Sep 30 2020kr.20mkr.11m

kr.4b

Jun 30 2020n/an/a

kr.4b

Mar 31 2020n/an/a

kr.4b

Dec 31 2019n/an/a

kr.4b

Sep 30 2019kr.17mkr.10m

kr.4b

Jun 30 2019n/an/a

kr.4b

Mar 31 2019n/an/a

kr.4b

Dec 31 2018n/an/a

kr.4b

Sep 30 2018kr.11mkr.6m

kr.4b

Jun 30 2018n/an/a

kr.4b

Mar 31 2018n/an/a

kr.4b

Dec 31 2017n/an/a

kr.4b

Sep 30 2017kr.10mkr.6m

kr.4b

Vergütung im Vergleich zum Markt: KristianDie Gesamtvergütung ($USD3.39M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Danish ($USD4.23M).

Entschädigung vs. Einkommen: KristianDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Kristian Villumsen (54 yo)

5.5yrs

Amtszeit

kr.23,300,000

Vergütung

Mr. Kristian Villumsen has been Independent Director of Demant A/S since March 5, 2021. He has been the President and Chief Executive Officer of Coloplast A/S since December 4, 2018. Mr. Villumsen was an E...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Kristian Villumsen
President & CEO5.5yrskr.23.30m0.045%
DKK 86.3m
Anders Lonning-Skovgaard
Executive VP & CFO9.9yrskr.11.90m0.0012%
DKK 2.3m
Allan Rasmussen
Executive Vice President of Global Operations9.9yrskr.10.50m0%
DKK 0
Nicolai Andersen
Executive Vice President of Innovationno datakr.10.00mkeine Daten
Paul Marcun
Executive Vice President of Growth5.4yrskr.12.00mkeine Daten
Thomas Barfod
Senior Controller & Employees Representative Directorno datakr.450.00k0.000020%
DKK 38.3k
Ellen Bjurgert
Vice President of Investor Relations7.7yrskeine Datenkeine Daten
Dennis Kaysen
Director of Corporate Communicationsno datakeine Datenkeine Daten
Dorthe Ronnau
Senior Vice President of People & Culture2.4yrskeine Datenkeine Daten
Alain Morvan
Senior Vice President of Sales Europe12.2yrskeine Datenkeine Daten
Rasmus Møller
Senior Vice President of Wound & Skin Care3.8yrskeine Datenkeine Daten
Manu Varma
Senior Vice President of Chronic Care - North America6.2yrskeine Datenkeine Daten

6.2yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: Das Managementteam von COLO B ist erfahren und erfahren (durchschnittliche Amtszeit: 6.1 Jahre).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Thomas Barfod
Senior Controller & Employees Representative Director18.4yrskr.450.00k0.000020%
DKK 38.3k
Carsten Hellmann
Independent Director6.5yrskr.690.00k0.0027%
DKK 5.1m
Lars Rasmussen
Chairman of the Board5.5yrskr.1.84m0.092%
DKK 176.6m
Niels Louis-Hansen
Deputy Chairman56.4yrskr.938.00k1.93%
DKK 3.7b
Marianne Wiinholt
Independent Director3.5yrskr.880.00k0.00022%
DKK 421.2k
Jette Nygaard-Andersen
Independent Director8.5yrskr.600.00kkeine Daten
Nikolaj Gundersen
Employees Representative Director6.4yrskr.450.00kkeine Daten
Roland Pedersen
Employees Representative Director6.4yrskr.450.00k0.00072%
DKK 1.4m
Annette Bruls
Independent Director2.5yrskr.600.00kkeine Daten

6.4yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: COLO BDie Vorstandsmitglieder gelten als erfahren (6.3 Jahre durchschnittliche Amtszeit).